SCHEMBL216979

SCHEMBL216979

CC(C)(C)c1ccc(S(OS(=O)(=O)CS(=O)(=O)OS(c2ccc(C(C)(C)C)cc2)(c2ccc(C(C)(C)C)cc2)c2ccc(C(C)(C)C)cc2)(c2ccc(C(C)(C)C)cc2)c2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
BCHE P06276 1/20 0.44
ACHE P22303 1/20 0.44
CA1 P00915 5/20 0.42
CA2 P00918 5/20 0.42
CA9 Q16790 1/20 0.42
LMNA P02545 3/20 0.41
HSD11B1 P28845 3/20 0.41
GAA P10253 1/20 0.41
HSD17B3 P37058 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 3/20 0.40
HPGD P15428 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
MEN1 O00255 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C19 P33261 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL218045 0.89 ALDH1A1 (0.50) ALDH1A1BCHEACHECA1CA2
SCHEMBL219017 0.86 ALDH1A1 (0.52) ALDH1A1BCHEACHECA1CA2
SCHEMBL7708810 0.84 ALDH1A1 (0.47) ALDH1A1BCHEACHECA1CA2
SCHEMBL7578164 0.83 ALDH1A1 (0.47) ALDH1A1BCHEACHECA1CA2
SCHEMBL7896349 0.81 ALDH1A1 (0.53) ALDH1A1BCHEACHECA1CA2
SCHEMBL7575486 0.79 ALDH1A1 (0.43) ALDH1A1BCHEACHECA1CA2
SCHEMBL450158 0.78 ALDH1A1 (0.40) ALDH1A1HSD11B1HSD17B3MAPTTDP1
SCHEMBL220568 0.76 ALDH1A1 (0.48) ALDH1A1BCHEACHECA1CA2
SCHEMBL7028778 0.75 BCHE (0.53) ALDH1A1BCHEACHECA1CA2
SCHEMBL451539 0.75 HSD11B1 (0.53) ALDH1A1CA1CA2CA9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088548-B2 Bottom antireflective coating compositions AZ ELECTRONIC MATERIALS USA CORP. (US) 2012-01-03 US claimed
EP-2212273-A2 BOTTOM ANTIREFLECTIVE COATING COMPOSITIONS AZ Electronic Materials USA Corp. (US) 2010-08-04 EP claimed
WO-2009053832-A2 BOTTOM ANTIREFLECTIVE COATING COMPOSITIONS AZ ELECTRONIC MATERIALS USA CORP. (DE) 2009-04-30 WO claimed
US-20090104559-A1 Bottom Antireflective Coating Compositions MERCK PATENT GMBH (DE) 2009-04-23 US claimed
US-8088548-B2 Bottom antireflective coating compositions AZ ELECTRONIC MATERIALS USA CORP. (US) 2012-01-03 US disclosed
US-20090104559-A1 Bottom Antireflective Coating Compositions MERCK PATENT GMBH (DE) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090104559-A1 Bottom Antireflective Coating Compositions SDC2, S100A9, MYH9 ALDH1A1 3154/4885BCHE 1358/4885ACHE 3212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.